Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors
  • Library

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Kingdom of Saudi Arabia
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Injectable Aesthetics
    • Dermatological Skincare
    • Therapeutic Dermatology
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2024
    • The aesthetic impact of medication-driven weight loss
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Podcasts
  • Innovation
    • Skin Science by Galderma
    • Bringing innovation to life
    • Partnering
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • For society
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Home
  • Investors

Nestlé Skin Health to acquire Innéov Assets

Press release

Nestlé Skin Health Launches SHIELD Center in Shanghai to Enable and Advance Healthy and Active Ageing

Press release

Nestlé Skin Health builds CHF 54 million factory in Brazil

Press release

Nestlé Skin Health Promotes a Life Course of Healthy Skin and Provides New Educational Tools During Active Aging Week 2015

Press release

Nestlé Skin Health Invests $46 Million in Factory Extension in Canada

Press release

Nestlé Skin Health Appoints Dr. Johannes J. Baensch as Chief Scientific Officer

Press release

ATP and Nestlé Skin Health’s Daylong Announce Exclusive Global Sun Care Partnership

Press release

Nestlé Skin Health to Form Non-Prescription Acne Joint Venture with Guthy-Renker

Press release

Nestlé Skin Health SHIELD Receives Corporate Leadership Award from the American Skin Association

Press release

Galderma Trifarotene Development Program Meets Key Milestone for Lamellar Ichthyosis Orphan Disease

Press release

Pagination

  • Previous page Previous Page
  • Next page Next Page
Subscribe to Press release
  1. Home
  2. Press release

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2026

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back